These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
378 related articles for article (PubMed ID: 33199997)
1. Lactoferrin for the treatment of COVID-19 (Review). Wang Y; Wang P; Wang H; Luo Y; Wan L; Jiang M; Chu Y Exp Ther Med; 2020 Dec; 20(6):272. PubMed ID: 33199997 [TBL] [Abstract][Full Text] [Related]
2. An overview on in vitro and in vivo antiviral activity of lactoferrin: its efficacy against SARS-CoV-2 infection. Rosa L; Cutone A; Conte MP; Campione E; Bianchi L; Valenti P Biometals; 2023 Jun; 36(3):417-436. PubMed ID: 35920949 [TBL] [Abstract][Full Text] [Related]
3. Lactoferrin for COVID-19 prevention, treatment, and recovery. Bolat E; Eker F; Kaplan M; Duman H; Arslan A; Saritaş S; Şahutoğlu AS; Karav S Front Nutr; 2022; 9():992733. PubMed ID: 36419551 [TBL] [Abstract][Full Text] [Related]
4. Can Lactoferrin, a Natural Mammalian Milk Protein, Assist in the Battle against COVID-19? Einerhand AWC; van Loo-Bouwman CA; Weiss GA; Wang C; Ba G; Fan Q; He B; Smit G Nutrients; 2022 Dec; 14(24):. PubMed ID: 36558432 [TBL] [Abstract][Full Text] [Related]
5. Lactoferrin as potential preventative and adjunct treatment for COVID-19. Chang R; Ng TB; Sun WZ Int J Antimicrob Agents; 2020 Sep; 56(3):106118. PubMed ID: 32738305 [TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of lactoferrin-coated zinc nanoparticles on SARS-CoV-2 replication and entry along with improvement of lung fibrosis induced in adult male albino rats. El-Fakharany EM; El-Gendi H; El-Maradny YA; Abu-Serie MM; Abdel-Wahhab KG; Shabana ME; Ashry M Int J Biol Macromol; 2023 Aug; 245():125552. PubMed ID: 37356684 [TBL] [Abstract][Full Text] [Related]
7. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses. Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205 [TBL] [Abstract][Full Text] [Related]
8. Protective Effects of Lactoferrin against SARS-CoV-2 Infection In Vitro. Salaris C; Scarpa M; Elli M; Bertolini A; Guglielmetti S; Pregliasco F; Blandizzi C; Brun P; Castagliuolo I Nutrients; 2021 Jan; 13(2):. PubMed ID: 33498631 [TBL] [Abstract][Full Text] [Related]
9. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2. Zhang XY; Huang HJ; Zhuang DL; Nasser MI; Yang MH; Zhu P; Zhao MY Infect Dis Poverty; 2020 Jul; 9(1):99. PubMed ID: 32690096 [TBL] [Abstract][Full Text] [Related]
10. Immunomodulatory agents as potential therapeutic or preventive strategies for COVID-19. Gaziano R; Pistoia ES; Campione E; Fontana C; Marino D; Favaro M; Pica F; Di Francesco P Eur Rev Med Pharmacol Sci; 2021 Jun; 25(11):4174-4184. PubMed ID: 34156699 [TBL] [Abstract][Full Text] [Related]
11. Ambulatory COVID-19 Patients Treated with Lactoferrin as a Supplementary Antiviral Agent: A Preliminary Study. Rosa L; Tripepi G; Naldi E; Aimati M; Santangeli S; Venditto F; Caldarelli M; Valenti P J Clin Med; 2021 Sep; 10(18):. PubMed ID: 34575388 [TBL] [Abstract][Full Text] [Related]
12. Bovine lactoferrin for the prevention of COVID-19 infection in health care personnel: a double-blinded randomized clinical trial (LF-COVID). Navarro R; Paredes JL; Tucto L; Medina C; Angles-Yanqui E; Nario JC; Ruiz-Cabrejos J; Quintana JL; Turpo-Espinoza K; Mejia-Cordero F; Aphang-Lam M; Florez J; Carrasco-Escobar G; Ochoa TJ Biometals; 2023 Jun; 36(3):463-472. PubMed ID: 36474100 [TBL] [Abstract][Full Text] [Related]
13. COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses. Shereen MA; Khan S; Kazmi A; Bashir N; Siddique R J Adv Res; 2020 Jul; 24():91-98. PubMed ID: 32257431 [TBL] [Abstract][Full Text] [Related]
14. Broad-spectrum coronavirus antiviral drug discovery. Totura AL; Bavari S Expert Opin Drug Discov; 2019 Apr; 14(4):397-412. PubMed ID: 30849247 [TBL] [Abstract][Full Text] [Related]
15. Human and novel coronavirus infections in children: a review. Rajapakse N; Dixit D Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199 [TBL] [Abstract][Full Text] [Related]
16. Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection. Liang Y; Wang ML; Chien CS; Yarmishyn AA; Yang YP; Lai WY; Luo YH; Lin YT; Chen YJ; Chang PC; Chiou SH Front Immunol; 2020; 11():1022. PubMed ID: 32574260 [TBL] [Abstract][Full Text] [Related]
17. Bovine lactoferrin inhibits SARS-CoV-2 and SARS-CoV-1 by targeting the RdRp complex and alleviates viral infection in the hamster model. He ST; Qin H; Guan L; Liu K; Hong B; Zhang X; Lou F; Li M; Lin W; Chen Y; He C; Liu F; Lu S; Luo S; Zhu S; An X; Song L; Fan H; Tong Y J Med Virol; 2023 Jan; 95(1):e28281. PubMed ID: 36329614 [TBL] [Abstract][Full Text] [Related]
18. Early human milk lactoferrin during SARS-CoV-2 infection. Briana DD; Papadopoulou A; Syridou G; Marchisio E; Kapsabeli E; Daskalaki A; Papaevangelou V J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6704-6707. PubMed ID: 33969775 [TBL] [Abstract][Full Text] [Related]
19. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Guo YR; Cao QD; Hong ZS; Tan YY; Chen SD; Jin HJ; Tan KS; Wang DY; Yan Y Mil Med Res; 2020 Mar; 7(1):11. PubMed ID: 32169119 [TBL] [Abstract][Full Text] [Related]
20. Current Strategies of Antiviral Drug Discovery for COVID-19. Mei M; Tan X Front Mol Biosci; 2021; 8():671263. PubMed ID: 34055887 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]